939 Stock Overview
Treatment.Com International Inc. provides personalized health care information services in Canada.
Snowflake Score | |
---|---|
Valuation | 0/6 |
Future Growth | 0/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Treatment.com AI Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | CA$0.37 |
52 Week High | CA$0.79 |
52 Week Low | CA$0.0001 |
Beta | -0.23 |
1 Month Change | -29.62% |
3 Month Change | 28.87% |
1 Year Change | 62.67% |
3 Year Change | n/a |
5 Year Change | n/a |
Change since IPO | -99.05% |
Recent News & Updates
Recent updates
Shareholder Returns
939 | DE Healthcare Services | DE Market | |
---|---|---|---|
7D | 8.3% | 0.6% | 1.1% |
1Y | 62.7% | -25.0% | 6.5% |
Return vs Industry: 939 exceeded the German Healthcare Services industry which returned -25.3% over the past year.
Return vs Market: 939 exceeded the German Market which returned 5.9% over the past year.
Price Volatility
939 volatility | |
---|---|
939 Average Weekly Movement | 26.6% |
Healthcare Services Industry Average Movement | 4.0% |
Market Average Movement | 5.0% |
10% most volatile stocks in DE Market | 10.4% |
10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 939's share price has been volatile over the past 3 months.
Volatility Over Time: 939's weekly volatility has decreased from 12638% to 27% over the past year, but is still higher than 75% of German stocks.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2018 | 3 | Essam Hamza | www.treatment.com |
Treatment Com International Inc. provides personalized health care information services in Canada. The company develops a mobile application for symptom assessment of users to address their health concerns, problems, and ongoing wellness management.
Treatment.com AI Inc. Fundamentals Summary
939 fundamental statistics | |
---|---|
Market cap | €15.67m |
Earnings (TTM) | -€1.36m |
Revenue (TTM) | €25.82k |
606.8x
P/S Ratio-11.5x
P/E RatioIs 939 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
939 income statement (TTM) | |
---|---|
Revenue | CA$38.14k |
Cost of Revenue | CA$13.95k |
Gross Profit | CA$24.19k |
Other Expenses | CA$2.03m |
Earnings | -CA$2.01m |
Last Reported Earnings
Sep 30, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.051 |
Gross Margin | 63.43% |
Net Profit Margin | -5,268.63% |
Debt/Equity Ratio | -91.6% |
How did 939 perform over the long term?
See historical performance and comparison